Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

類似資料

• Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia
  著者:: Boord, Jeffrey B., 等
  出版事項: (2002)
• Adipocyte/macrophage fatty acid–binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice
  著者:: Furuhashi, Masato, 等
  出版事項: (2008)
• Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
  著者:: Makowski, Liza, 等
  出版事項: (2001)
• Double-stranded RNA-dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis
  著者:: Nakamura, Takahisa, 等
  出版事項: (2010)
• Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice
  著者:: Boord, Jeffrey B., 等
  出版事項: (2004)